ANASTASIA DAVIS: Open Payments
NPI 1487197505 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,517 in 129 payments from 15 companies in 2025. Trend: 2023 $720 · 2024 $2,036 · 2025 $2,517
Food & beverage: $2,517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $616 |
| Madrigal Pharmaceuticals | 13 | $341 |
| QOL Medical, LLC | 17 | $311 |
| Ardelyx, Inc. | 16 | $302 |
| Phathom Pharmaceuticals, Inc. | 10 | $262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $212 |
| Janssen Biotech, Inc. | 9 | $162 |
| Gilead Sciences, Inc. | 4 | $90 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 2 | $40 |
Products named: REZDIFFRA, Sucraid, IBSRELA, VOQUEZNA, ENTYVIO, RINVOQ, LINZESS, TREMFYA.
Industry payments across GA — which companies pay providers there.
